This study evaluated the influence of diabetes on the relationship between N-terminal pro-B-type natriuretic peptide (NT-proBNP) and body mass index (BMI). Simultaneous NT-proBNP and echocardiographic Doppler examinations were performed in 1117 patients with dyspnoea undergoing cardiac catheterization. Patients were divided into BMI ≥ 25 kg/m2 (obese), 23 − 25 kg/m2 (overweight) and < 23 kg/m2 (non-obese) groups. In the 803 non-diabetic patients, mean plasma NT-proBNP levels in non-obese, overweight and obese patients showed a significant negative correlation with BMI (862.3 ± 228.8 pg/ml, 611.5 ± 149.7 pg/ml, 278.3 ± 172.5 pg/ml, respectively). In the 314 patients with diabetes, there was no correlation between BMI and NT-proBNP. This study demonstrated that obese patients had reduced concentrations of NT-proBNP compared with non-obese patients, despite having higher left ventricular filling pressures. NT-proBNP was not reduced in obese patients with diabetes. These results suggest that factors other than cardiac status impact on NT-proBNP concentration.
MaiselASKrishnaswamyPNowakRM: Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med2002; 347: 161–167.
2.
MaedaKTsutamotoTWadaA: Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J1998; 135: 825–832.
3.
FriedlWMairJThomasS: Natriuretic peptides and cyclic guanosine 3′,5′-monophosphate in asymptomatic and symptomatic left ventricular dysfunction. Heart1996; 76: 129–136.
4.
MaiselASCloptonPKrishnaswamyP: Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: Results from the Breathing Not Properly (BNP) multinational study. Am Heart J2004; 147: 1078–1084.
5.
WangTJLarsonMGLevyD: Impact of obesity on plasma natriuretic peptide levels. Circulation2004; 109: 594–600.
6.
KraussRMWinstonMFletcherBJ: Obesity: Impact on cardiovascular disease. Circulation1998; 98: 1472–1476.
7.
AlpertMALambertCRTerryBE: Influence of left ventricular mass on left ventricular diastolic filling in normotensive morbid obesity. Am Heart J1995; 130: 1068–1073.
8.
RiveraMCortésRSalvadorA: Obese subjects with heart failure have lower N-terminal pro-brain natriuretic peptide plasma levels irrespective of etiology. Eur J Heart Fail2005; 7: 1168–1170.
9.
TaylorJAChristensonRHRaoK: B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures. Am Heart J2006; 152: 1071–1076.
10.
GörmüşUOzmenDOzmenB: Serum N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction. Diabetes Res Clin Pract2010; 87: 51–56.
11.
AHA Science Advisory: Assessment of functional capacity in clinical and research applications. Circulation2000; 102: 1591–1597.
12.
American Diabetes Association: Standards of medical care in diabetes–2009. Diabetes Care2009; 32 (suppl 1): S13–S61.
13.
KohJHKohSBLeeMY: Optimal waist circumference cutoff values for metabolic syndrome diagnostic criteria in a Korean rural population. J Korean Med Sci2010; 25: 734–737.
14.
CheitlinMDArmstrongWFAurigemmaGP: ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation2003; 108: 1146–1162.
15.
DevereuxRBAlonsoDRLutasEM: Echocardiographic assessment of left ventricular hypertrophy: Comparison with necropsy findings. Am J Cardiol1986; 57: 450–458.
16.
GanauADevereuxRBRomanMJ: Patterns of left ventricular hypertrophy and geometric remodelling in essential hypertension. J Am Coll Cardiol1992; 19: 1550–1558.
17.
TeiCNishimuraRASewardJB: Noninvasive Doppler-derived myocardial performance index: Correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr1997; 10: 169–178.
18.
HallC: Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail2004; 6: 257–260.
19.
KimSHKimJSBaekKK: Role of NT-proBNP in evaluation of functional status in congestive heart failure. Korean Circ J2004; 34: 894–899.
20.
ChoiJY: The role of brain natriuretic peptide in the patients with acute dyspnea in the emergency department. Korean Circ J2007; 37: 464–469.
21.
LuersCWachterRKletaS: Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction. Clin Res Cardiol2010; 99: 217–226.
22.
DaoQKrishnaswamyPKazanegraR: Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol2001; 37: 379–385.
23.
OlsenMHHansenTWChristensenMK: N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension2005; 46: 660–666.
24.
McCordJMundyBJHudsonMP: Relationship between obesity and B-type natriuretic peptide levels. Arch Intern Med2004; 164: 2247–2252.
25.
HorwichTBFonarowGCHamiltonMA: The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol2001; 38: 789–795.
26.
LevineBKalmanJMayerL: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med1990; 323: 236–241.
27.
SarzaniRDessi-FulgheriPPaciVM: Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest1996; 19: 581–585.
28.
OmmenSRNishimuraRAAppletonCP: Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation2000; 102: 1788–1794.
29.
SengenesC: Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women. Int J Obes Relat Metab Disord2002; 26: 24–32.
30.
KalraPRTigasS: Regulation of lipolysis: Natriuretic peptides and the development of cachexia. Int J Cardiol2002; 85: 125–132.
31.
BhallaMAChiangAEpshteynVA: Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol2004; 44: 1047–1052.
